Delivery Order SPE2DB20D2104-SPE2DB22FR58Y
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. The $5,110.47 firm fixed-price delivery order contract has a completion date of May 4, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $10,220.94 for NUCALA 100 MG/ML AUTO-INJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,044.96 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, a pharmaceutical product. The $10,220.94 contract was awarded on March 24, 2022 by the Defense Logistics Agency, a defense agency, and has an ultimate completion date of April 14, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type, and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides the Defense Logistics Agency (DLA) Troop Support Medical with a comprehensive range of pharmaceutical products and medical supplies. The $1,703.50 delivery order covers various medications, including the specialty drug Nucala, as well as other critical medical commodities such as syringes, vials, and test kits. The contract is not designated with a set-aside requirement, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,703.49 for 4555786422 NUCALA 100 MG/ML AUTO-INJECTORML. The award was made by the Defense Logistics Agency (DLA), a major component of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the DoD...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,318.85 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 15, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,407.00 for the provision of the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly those...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,110.47 delivery order is for NUCALA 100 MG/ML AUTO-INJECTORML, a specialty medication, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR58YDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, a specialty pharmaceutical product. The $6,813.96 firm-fixed-price delivery order has a completion date of February 11, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes medications, vaccines, syringes, and other critical medical commodities. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/21/22 |